FDA Application
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Application

  • Print
  • Share
  • E-mail

Nystatin Oral Suspension USP
Company:  UDL Laboratories, Inc.
Application No.: ANDA 64-142
Approval Date:  6/25/98


Last update: June 30, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.